NCT02596958View on ClinicalTrials.gov

Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants

CompletedOBSERVATIONAL
Enrollment

996

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Interventions
DRUG

Bevacizumab

Six 3-weeks cycle of IV bevacizumab will be administered for approximately 7 months.

Trial Locations (1)

38642

Goslar

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02596958 - Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants | Biotech Hunter | Biotech Hunter